Sural-to-radial amplitude ratio in the diagnosis of diabetic sensorimotor polyneuropathy.Muscle Nerve. 2012 Jan; 45(1):126-7.MN
Abstract
In this investigation we measured sural and radial sensory potentials and the sural/radial amplitude ratio (SRAR) in 49 patients with diabetes and diabetic sensorimotor polyneuropathy (DSP) according to consensus criteria. Forty-five (92%) of the patients had a Toronto Clinical Neuropathy Score (TCNS) ≤5, which is consistent with a diagnosis of DSP. Using a threshold for SRAR of <0.21, we found no advantage of using the SRAR over the sural nerve potential amplitude alone in sensitivity for identification of DSP.
Links
MeSH
Pub Type(s)
Journal Article
Language
eng
PubMed ID
22190318
Citation
Barnett, Carolina, et al. "Sural-to-radial Amplitude Ratio in the Diagnosis of Diabetic Sensorimotor Polyneuropathy." Muscle & Nerve, vol. 45, no. 1, 2012, pp. 126-7.
Barnett C, Perkins BA, Ngo M, et al. Sural-to-radial amplitude ratio in the diagnosis of diabetic sensorimotor polyneuropathy. Muscle Nerve. 2012;45(1):126-7.
Barnett, C., Perkins, B. A., Ngo, M., Todorov, S., Leung, R., & Bril, V. (2012). Sural-to-radial amplitude ratio in the diagnosis of diabetic sensorimotor polyneuropathy. Muscle & Nerve, 45(1), 126-7. https://doi.org/10.1002/mus.22166
Barnett C, et al. Sural-to-radial Amplitude Ratio in the Diagnosis of Diabetic Sensorimotor Polyneuropathy. Muscle Nerve. 2012;45(1):126-7. PubMed PMID: 22190318.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Sural-to-radial amplitude ratio in the diagnosis of diabetic sensorimotor polyneuropathy.
AU - Barnett,Carolina,
AU - Perkins,Bruce A,
AU - Ngo,Mylan,
AU - Todorov,Slavko,
AU - Leung,Rita,
AU - Bril,Vera,
PY - 2011/12/23/entrez
PY - 2011/12/23/pubmed
PY - 2012/2/9/medline
SP - 126
EP - 7
JF - Muscle & nerve
JO - Muscle Nerve
VL - 45
IS - 1
N2 - In this investigation we measured sural and radial sensory potentials and the sural/radial amplitude ratio (SRAR) in 49 patients with diabetes and diabetic sensorimotor polyneuropathy (DSP) according to consensus criteria. Forty-five (92%) of the patients had a Toronto Clinical Neuropathy Score (TCNS) ≤5, which is consistent with a diagnosis of DSP. Using a threshold for SRAR of <0.21, we found no advantage of using the SRAR over the sural nerve potential amplitude alone in sensitivity for identification of DSP.
SN - 1097-4598
UR - https://www.unboundmedicine.com/medline/citation/22190318/Sural_to_radial_amplitude_ratio_in_the_diagnosis_of_diabetic_sensorimotor_polyneuropathy_
DB - PRIME
DP - Unbound Medicine
ER -